淋巴结最高FDG摄取预测局部晚期鼻咽癌患者无远处转移生存
回顾性分析51例III、IVA、IVB期鼻咽癌患者分期时的18F-FDG PET/CT,以肝脏SUVmean为参照计算原发灶TLR、最高摄取淋巴结NLR-H及最远站淋巴结NLR-F。中位随访50.4±39.3个月期间11例(21.6%)发生远处转移。单因素及多因素分析显示N3b(P=0.003)和NLR-H>5.70(P=0.02)为DMFS的显著预后因素,TLR(P=0.18)和NLR-F(P=0.76)不显著。Kaplan-Meier曲线显示NLR-H>5.70组DMFS显著差于NLR-H≤5.70组(1年DMFS率84.2% vs 93.5%;P=0.01)。
要点
- NLR-H>5.70是局部晚期鼻咽癌DMFS的独立不良预后因素(多因素分析P=0.02)。
- N3b也是DMFS的显著预后因素(P=0.003),多因素分析中仍显著。
- NLR-H>5.70组1年DMFS率84.2%,低于NLR-H≤5.70组的93.5%(P=0.01)。
核心结论
- 除解剖学N分期外,治疗前18F-FDG PET/CT上较高的NLR-H是局部晚期鼻咽癌患者较差DMFS的独立预后因素。
研究设计与样本
- 回顾性分析51例III、IVA、IVB期鼻咽癌患者,均在分期时接受18F-FDG PET/CT检查。
- 将原发灶SUVmax、最高摄取淋巴结SUVmax及最远站淋巴结SUVmax分别除以背景肝脏SUVmean,得到TLR、NLR-H和NLR-F。
- 采用Cox比例风险模型评估临床病理因素及SUV参数的DMFS预测价值,用Kaplan-Meier法比较DMFS差异。
主要发现
- 中位随访50.4±39.3个月(中位数±四分位距;范围3.8-130.9个月)期间,11例(21.6%)发生远处转移。
- 单因素分析中,N分期(N3b)(P=0.003)和NLR-H>5.70(P=0.02)为DMFS的显著预后因素,多因素分析中仍显著。
- TLR(P=0.18)和NLR-F(P=0.76)不是DMFS的显著预后因素。
- Kaplan-Meier曲线显示NLR-H>5.70组DMFS显著差于NLR-H≤5.70组(1年DMFS率84.2% vs 93.5%;P=0.01)。
关键数值与推荐
- NLR-H>5.70为DMFS的显著不良预后因素(单因素P=0.02,多因素分析仍显著)。
- N3b为DMFS的显著预后因素(P=0.003,多因素分析仍显著)。
- NLR-H>5.70组1年DMFS率84.2% vs NLR-H≤5.70组93.5%(P=0.01)。
- TLR(P=0.18)和NLR-F(P=0.76)与DMFS无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Distant failure is a major concern in patients with nasopharyngeal carcinoma. We evaluated whether the metabolic features on F-FDG PET/CT can predict distant metastasis-free survival (DMFS) in patients with locally advanced nasopharyngeal carcinoma. METHODS: We retrospectively reviewed 51 patients stage III, IVA, and IVB nasopharyngeal carcinoma who underwent F-FDG PET/CT at staging. The SUVmax for the primary site and the lymph nodes with the highest uptake as well as at the farthest station were divided by the SUVmean of the background liver (TLR, NLR-H, and NLR-F, respectively). The prognostic value of clinicopathologic factors and SUV parameters for predicting DMFS were assessed using a Cox proportional hazards model. Differences in DMFS were examined by the Kaplan-Meier method. RESULTS: In the median follow-up period of 50.4 ± 39.3 months (median ± interquartile range; range, 3.8-130.9), distant metastasis developed in 11 patients (21.6%). In univariate analyses, N stage (N3b) (P = 0.003) and NLR-H >5.70 (P = 0.02) were significant prognostic factors for DMFS, and remained significant in multivariate analysis, whereas TLR (P = 0.18) and NLR-F (P = 0.76) did not. The Kaplan-Meier curves showed significantly poorer DMFS in patients with NLR-H >5.70 than in those with lower NLR-H (≤5.70) (1-year DMFS rate, 84.2% vs 93.5%; P = 0.01). CONCLUSIONS: In addition to anatomical N stage, higher NLR-H on pretreatment F-FDG PET/CT is an independent prognostic factor for worse DMFS in patients with locally advanced nasopharyngeal carcinoma.
引用
- Cho H, Kim SH, Kim H, et al. Lymph Node With the Highest FDG Uptake Predicts Distant Metastasis-Free Survival in Patients With Locally Advanced Nasopharyngeal Carcinoma. Clin Nucl Med. 2018. PMID: 29762247. doi:10.1097/RLU.0000000000002145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。